2021-2023年度代表性论文

1. Li Z^#, Peng B^#, Chen S, Li J, Hu K, Liao L, Xie Q, Yao M, Liang L, Tomlinson S, Yuan G^*, He S^*. Transcriptome sequencing and metabolome analysis reveal the metabolic reprogramming of partial hepatectomy and extended hepatectomy. BMC Genomics. 2023 Sep 7; 24(1):532.

2. Jiang K^#, Lu S^#, Li D, Liu M, Jin H, Lei B, Wang S, Long K, He S, Zhong F. Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization. J Gastroenterol. 2023 Sep; 58(9):894-907.

3. Zhao H, Wang Y, Yang Y. Follicular development and ovary aging: single-cell studies. Biol Reprod. 2023 Jul 28:ioad080.

4. Meng Z, Li P, Yang D, Huang H, Dong H, Qin Y, Bin Y, Li R, Wang S, Chen X, Kang M. The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline. Radiother Oncol. 2023 Nov 24; 191:110027.

5. Lin C^#, Lei B^#, Dong C^#, Chen J, Chen S, Jiang K, Zeng Y, Su H, Jin H, Qiu X, Li Z, Hu Z, Yu S, Zhang C, Lu S, Atkinson C, Tomlinson S, Zhong F^*, Yuan G^*, He S^*. Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling. Am J Transplant. 2023 Apr; 23(4):484-497.

6. Guo Z^#, Chen J^#, Zeng Y, Wang Z, Yao M, Tomlinson S, Chen B^*, Yuan G^*, He S^*. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice. Front Immunol. 2022 Jan 7; 12:785287.

7. Zheng C, Sleiman MM, Yang X, He S, Atkinson C, Tomlinson S. Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope. J Heart Lung Transplant. 2021 Oct; 40(10):1112-1121.

8. Lei B^#, Sleiman MM^#, Cheng Q, Tu Z, Zhu P, Goddard M, Martins PN, Langerude L, Nadig S, Tomlinson S^*, Atkinson C^*. In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries. Front Immunol. 2021 Jul 29; 12:630581.